1,3,4-trisubstituted pyrrolidinones as scaffolds for construction of peptidomimetic cholecystokinin antagonists
- 31 October 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (10), 1251-1256
- https://doi.org/10.1016/s0960-894x(00)80224-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 1991
- Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humansGastroenterology, 1991
- Brain CCKA receptors mediate the colonic motor response to feeding in dogsPeptides, 1991
- Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.Proceedings of the National Academy of Sciences, 1991
- Postponement of Satiety by Blockade of Brain Cholecystokinin (CCK-B) ReceptorsScience, 1989
- Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy VolunteersArchives of General Psychiatry, 1989
- Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329Neuropharmacology, 1989
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.Proceedings of the National Academy of Sciences, 1986
- Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.The Journal of Antibiotics, 1985
- Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the ratEuropean Journal of Pharmacology, 1982